Reduced nitric oxide in diabetic kidneys due to increased hepatic arginine metabolism: Implications for renomedullary oxygen availability

American Journal of Physiology - Renal Physiology

Volumn 294, Issue 1, 2008, Pages

  Palm, Fredrik ^a,c   Friederich, Malou ^a   Carlsson, Per Ola ^a   Hansell, Peter ^a   Teerlink, Tom ^b   Liss, Per ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

Asymmetric dimethylarginine; Blood flow; Diabetes mellitus; Oxidative stress; Plasma arginine; Vationic amino acid transporter

Indexed keywords

ALPHA TOCOPHEROL; ARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; ORNITHINE; OXYGEN; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; KIDNEY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXYGEN TENSION; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; WISTAR FURTH RAT;

EID: 38349070587     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00166.2007     Document Type: Article

References (45)

1. Adler S, Huang H, Loke KE, Xu X, Tada H, Laumas A, Hintze TH. Endothelial nitric oxide synthase plays an essential role in regulation of renal oxygen consumption by NO. Am J Physiol Renal Physiol 280: F838-F843, 2001.
2. Balcioglu A, Maher TJ. The measurement of nitric oxide release induced by kainic acid using a novel hemoglobin-trapping technique with microdialysis. Ann NY Acad Sci 738: 282-288, 1994.
3. Berchner-Pfannschmidt U, Yamac H, Trinidad B, Fandrey J. Nitric oxide modulates oxygen sensing by hypoxia-inducible factor 1-dependent induction of prolyl hydroxylase 2. J Biol Chem 282: 1788-1796, 2007.
4. Bode-Boger SM, Boger RH, Kienke S, Junker W, Frolich JC. Elevated L-arginine/dimethylarginine ratio contributes to enhanced systemic NO production by dietary L-arginine in hypercholesterolemic rabbits. Biochem Biophys Res Commun 219: 598-603, 1996.
5. Brezis M, Rosen S. Hypoxia of the renal medulla - its implication for disease. N Engl J Med 332: 647-655, 1995.
6. Buerk DG. Can we model nitric oxide biotransport? A survey of mathematical models for a simple diatomic molecule with surprisingly complex biological activities. Annu Rev Biomed Eng 3: 109-143, 2001.
7. Buerk DG, Lamkin-Kennard K, Jaron D. Modeling the influence of superoxide dismutase on superoxide and nitric oxide interactions, including reversible inhibition of oxygen consumption. Free Radic Biol Med 34: 1488-1503, 2003.
8. Cabrales P, Tsai AG, Frangos JA, Intaglietta M. Role of endothelial nitric oxide in microvascular oxygen delivery and consumption. Free Radic Biol Med 39: 1229-1237, 2005.
9. Castillo L, Sanchez M, Chapman TE, Ajami A, Burke JF, Young VR. The plasma flux and oxidation rate of ornithine adaptively decline with restricted arginine intake. Proc Natl Acad Sci USA 91: 6393-6397, 1994.
10. Cohen J, Kamm D. Renal metabolism: relation to renal function. In: The Kidney, edited by Brenner B and Rector F. Philadelphia, PA: Saunders, 1985, p. 144-248.
11. de Jong S, Teerlink T. Analysis of asymmetric dimethylarginine in plasma by HPLC using a monolithic column. Anal Biochem 353: 287-289, 2006.
12. Deng A, Miracle CM, Suarez JM, Lortie M, Satriano J, Thomson SC, Munger KA, Blantz RC. Oxygen consumption in the kidney: effects of nitric oxide synthase isoforms and angiotensin II. Kidney Int 68: 723-730, 2005.
13. Dhanakoti SN, Brosnan JT, Herzberg GR, Brosnan ME. Renal arginine synthesis: studies in vitro and in vivo. Am J Physiol Endocrinol Metab 259: E437-E442, 1990.
14. Endemann DH, Schiffrin EL. Nitric oxide, oxidative excess, and vascular complications of diabetes mellitus. Curr Hypertens Rep 6: 85-89, 2004.
15. Evans RG, Eppel GA, Anderson WP, Denton KM. Mechanisms underlying the differential control of blood flow in the renal medulla and cortex. J Hypertens 22: 1439-1451, 2004.
16. Govers R, Rabelink TJ. Cellular regulation of endothelial nitric oxide synthase. Am J Physiol Renal Physiol 280: F193-F206, 2001.
17. Hallemeesch MM, Lamers WH, Deutz NE. Reduced arginine availability and nitric oxide production. Clin Nutr 21: 273-279, 2002.
18. Kakoki M, Kim HS, Arendshorst WJ, Mattson DL. L-Arginine uptake affects nitric oxide production and blood flow in the renal medulla. Am J Physiol Regul Integr Comp Physiol 287: R1478-R1485, 2004.
19. Kitiyakara C, Chabrashvili T, Jose P, Welch WJ, Wilcox CS. Effects of dietary salt intake on plasma arginine. Am J Physiol Regul Integr Comp Physiol 280: R1069-R1075, 2001.
20. Koivisto A, Matthias A, Bronnikov G, Nedergaard J. Kinetics of the inhibition of mitochondrial respiration by NO. FEBS Lett 417: 75-80, 1997.
21. Koivisto A, Pittner J, Froelich M, Persson AE. Oxygen-dependent inhibition of respiration in isolated renal tubules by nitric oxide. Kidney Int 55: 2368-2375, 1999.
22. Laycock SK, Vogel T, Forfia PR, Tuzman J, Xu X, Ochoa M, Thompson CI, Nasjletti A, Hintze TH. Role of nitric oxide in the control of renal oxygen consumption and the regulation of chemical work in the kidney. Circ Res 82: 1263-1271, 1998.
23. Liss P, Nygren A, Revsbech NP, Ulfendahl H. Intrarenal oxygen tension measured by a modified Clark electrode at normal and low blood pressure and after injection of x-ray contrast media. Pflügers Arch 434: 705-711, 1997.
24. Miyata N, Zou AP, Mattson DL, Cowley AW Jr. Renal medullary interstitial infusion of L-arginine prevents hypertension in Dahl salt-sensitive rats. Am J Physiol Regul Integr Comp Physiol 275: R1667-R1673, 1998.
25. Morris SM Jr. Recent advances in arginine metabolism. Curr Opin Clin Nutr Metab Care 7: 45-51, 2004.
26. Nijveldt RJ, Teerlink T, Siroen MP, van Lambalgen AA, Rauwerda JA, van Leeuwen PA. The liver is an important organ in the metabolism of asymmetrical dimethylarginine (ADMA). Clin Nutr 22: 17-22, 2003.
27. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404: 787-790, 2000.
28. Pallone TL, Silldorff EP, Turner MR. Intrarenal blood flow: microvascular anatomy and the regulation of medullary perfusion. Clin Exp Pharmacol Physiol 25: 383-392, 1998.
29. Palm F. Intrarenal oxygen in diabetes and a possible link to diabetic nephropathy. Clin Exp Pharmacol Physiol 33: 997-1001, 2006.
30. Palm F, Buerk DG, Carlsson PO, Hansell P, Liss P. Reduced nitric oxide concentration in the renal cortex of streptozotocin-induced diabetic rats: effects on renal oxygenation and microcirculation. Diabetes 54: 3282-3287, 2005.
31. Palm F, Cederberg J, Hansell P, Liss P, Carlsson PO. Reactive oxygen species cause diabetes-induced decrease in renal oxygen tension. Diabetologia 46: 1153-1160, 2003.
32. Palm F, Hansell P, Ronquist G, Waldenstrom A, Liss P, Carlsson PO. Polyol-pathway-dependent disturbances in renal medullary metabolism in experimental insulin-deficient diabetes mellitus in rats. Diabetologia 47: 1223-1231, 2004.
33. Palm F, Liss P, Fasching A, Hansell P, Carlsson PO. Transient glomerular hyperfiltration in the streptozotocin-diabetic Wistar-Furth rat. Ups J Med Sci 106: 175-182, 2001.
34. Palm F, Ortsäter H, Hansell P, Liss P, Carlsson PO. Differentiating between effects of streptozotocin per se and subsequent hyperglycemia on renal function and metabolism in the streptozotocin-diabetic rat model. Diabetes Metab Res Rev 20: 452-459, 2004.
35. Revsbech NP. An oxygen microsensor with a guard cathode. Limnol Oceanogr 34: 474-478, 1989.
36. Rodriguez J, Maloney RE, Rassaf T, Bryan NS, Feelisch M. Chemical nature of nitric oxide storage forms in rat vascular tissue. Proc Natl Acad Sci USA 100: 336-341, 2003.
37. Salom MG, Arregui B, Carbonell LF, Ruiz F, Gonzalez-Mora JL, Fenoy FJ. Renal ischemia induces an increase in nitric oxide levels from tissue stores. Am J Physiol Regul Integr Comp Physiol 289: R1459-R1466, 2005.
38. Sjöquist M, Göransson A, Källskog Ö, Ulfendahl HR. The influence of tubulo-glomerular feedback on the autoregulation of filtration rate in superficial and deep glomeruli. Acta Physiol Scand 122: 235-242, 1984.
39. Teerlink T, Nijveldt RJ, de Jong S, van Leeuwen PA. Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography. Anal Biochem 303: 131-137, 2002.
40. Trapp G, Sydow K, Dulay MT, Chou T, Cooke JP, Zare RN. Capillary electrophoretic and micellar electrokinetic separations of asymmetric dimethyl-L-arginine and structurally related amino acids: quantitation in human plasma. J Sep Sci 27: 1483-1490, 2004.
41. Vallance P, Leone A, Calver A, Collier J, Moncada S. Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis. J Cardiovasc Pharmacol 20, Suppl 12: S60-S62, 1992.
42. 2 and renal oxygen usage in the hypertensive rat kidney. Kidney Int 59: 230-237, 2001.
43. Werner ER, Gorren AC, Heller R, Werner-Felmayer G, Mayer B. Tetrahydrobiopterin and nitric oxide: mechanistic and pharmacological aspects. Exp Biol Med (Maywood) 228: 1291-1302, 2003.
44. Zhang Y, Samson FE, Nelson SR, Pazdernik TL. Nitric oxide detection with intracerebral microdialysis: important considerations in the application of the hemoglobin-trapping technique. J Neurosci Methods 68: 165-173, 1996.
45. Zou AP, Cowley AW Jr. Nitric oxide in renal cortex and medulla. An in vivo microdialysis study. Hypertension 29: 194-198, 1997.